Catalyst Wire Dossier Catalyst Wire Dossier

Felzartamab

felzartamab · MorphoSys
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Felzartamab, covering 2024-04-18 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]

See pricing